Loading
Latest filing published 21 Jan 2026 for Jaguar Health, Inc..
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
All filings by Lisa A. Conte on record concern Jaguar Health, Inc., in the capacity of chief executive. Over a trading history stretching from 18 July 2018 to 11 December 2025, the count stands at 11 filings.
Purchases make up the whole of the open-market record (2 purchases, €18k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 3 share grants and 6 option exercises.
On 21 January 2026 came the latest disclosure, a share grant in Jaguar Health, Inc. The clock since the last published purchase (30 March 2022) now reads 1,669 days. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations